SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NIKI

Niki BioSolutions, Inc. (NIKI)

NASDAQ: NIKI · Real-Time Price · USD
Healthcare · Biotechnology
$1.60+$0.06 (+3.90%)
 
Market cap
$4.99M
Insider Score
Insider Score
––Not scored
NIKI Insider Score

No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.

NIKI Income Statement

Fiscal PeriodQ4 2025Q3 2025
Period EndingDec 31, 2025Sep 30, 2025
Revenue$0.00$0.00
Revenue Growth (YoY)——
Cost of Revenue——
Gross Profit——
SG&A Expense$617.20 K$411.90 K
R&D Expense$91.71 K$241.79 K
Operating Expenses$825.13 K$589.63 K
Operating Income-$825.13 K-$589.63 K
Pretax Income-$310.54 K-$616.60 K
Tax Provision——
Net Income-$307.50 K-$614.00 K
EPS (Basic)——
EPS (Diluted)——
Shares Outstanding——

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Niki BioSolutions, Inc. (NIKI) Financials: Revenue, Earnings & Balance Sheet | InsiderBuying.com